KIND TO BIOME

Quorum quenching & Cutibacterium acnes

Silence the signal, not the microbiome

Quorum quenching is a targeted way to disarm bacterial virulence without carpet-bombing the skin's ecosystem. Our Quorum Quenching Assay lets you measure, and substantiate, a formulation's ability to disrupt Cutibacterium acnes biofilm and cell-to-cell signalling, so your actives can claim mechanism, not just marketing.

Duotone blue scanning electron micrograph of skin bacteria
Photo slot — duotone blue SEM microbiome imagery

The mechanism

Bacteria talk. Quorum sensing is the conversation.

Bacteria don't act as isolated cells. They release small chemical signals, called autoinducers, that accumulate as the population grows. Once the signal concentration crosses a threshold, the whole community “knows” it has reached a critical density and switches on collective behaviours in unison. This density-dependent communication is called quorum sensing (QS).[1][2]

QS is the master switch behind the behaviours that matter most in skin health: biofilm formation, the release of virulence factors, and coordinated shifts in metabolism.[1][3] Different bacteria speak in different chemical languages, Gram-negative species largely use acyl-homoserine lactones (AHLs), Gram-positive species use autoinducing peptides (AIPs), and a shared signal (AI-2) lets different species eavesdrop on one another.[2][3] On the skin, this cross-talk is not just noise: it actively shapes which organisms dominate and how the barrier holds up.[11]

Quorum sensing: from low to high cell densityAt low cell density, signalling molecules stay dispersed and cells remain quiet. As the population grows, autoinducers accumulate past a threshold and the community switches on collective behaviours.Low density — signals dispersedThreshold reached —community activates

The intervention

Quorum quenching interrupts the message

If quorum sensing is the conversation, quorum quenching (QQ) is jamming the line. Rather than trying to kill bacteria, QQ interferes with their ability to coordinate, so the population never reaches the “switch on virulence” decision.[4]

There are three well-characterised ways to quench a quorum, and a formulation can exploit any of them:[4][5][6][7]

Close-up of skin showing inflammatory marks and blemishes associated with acne-related microbiome imbalance
Acne-prone skin with active inflammatory marks
Inhibit signal synthesisEnzyme inside the cell is blocked, so no autoinducer is produced.

Stop the signal being made

— inhibit the enzymes bacteria use to synthesise autoinducers.[4]

Degrade the signalA quorum-quenching enzyme cleaves the signalling molecule in transit.

Destroy the signal in transit

— quorum-quenching enzymes such as lactonases and acylases hydrolyse and inactivate the signalling molecules before they can be read.[5][6]

Block the receptorAn antagonist occupies the receptor so an arriving signal is not read.

Block the signal being read

— quorum-sensing inhibitors (QSIs) act as antagonists at the receptor, so even a signal that arrives goes unheard.[7]

The unifying idea: you change bacterial behaviour, not bacterial survival.[4][6]

Why it matters

Disarm, don't destroy — and the microbiome stays intact

Anti-virulence, not antibiosis. Conventional antimicrobials aim to kill. That works, but it applies enormous selective pressure, any resistant cell that survives inherits the whole niche, which is a primary driver of antibiotic resistance. Quorum quenching takes a different route: it “does not aim to kill the pathogen,” it disarms it.[6] By targeting virulence and biofilm rather than viability, QQ is widely framed as an anti-virulence strategy that exerts weaker selective pressure and is therefore expected to be far less prone to driving resistance.[6][8][9]

It preserves the ecosystem you actually want. Broad-spectrum antimicrobials don't distinguish friend from foe; they deplete the commensals that keep skin healthy. Because quorum quenching targets a signalling behaviour rather than killing cells indiscriminately, it can quiet a problematic behaviour while leaving the wider community standing, the difference between a scalpel and a scorched-earth approach. This is exactly what makes QQ compelling for microbiome-friendly product design.[6][10]

The skin already does this. Quorum quenching isn't a synthetic trick imposed on skin, it's a mechanism the skin microbiome uses to police itself. Commensal skin staphylococci produce autoinducing peptides that quench the Staphylococcus aureus agr quorum-sensing system, suppressing toxin production and protecting the skin barrier; in atopic dermatitis, a lower ratio of these commensal quenching signals to S. aureus tracks with worse disease.[11] A formulation that supports quorum quenching is working with the skin's own regulatory logic, not against it.

The acne case

Why quorum quenching is a natural fit for acne care

Acne is where the case for quorum quenching is strongest, and where the older “just kill C. acnes” model has most clearly broken down.

37% vs 13%

C. acnes macrocolonies/biofilms in acne facial biopsies versus controls — odds ratio 3.85.[16]

It's dysbiosis, not overgrowth. Cutibacterium acnes is a lifelong skin commensal, present on healthy and acne-prone skin alike. Landmark metagenomics showed that overall C. acnes abundance is similar between people with and without acne, what differs is the strain population structure, with specific lineages enriched in acne.[12] The field has since reframed acne as a loss of balance between C. acnes phylotypes and a broader dysbiosis of the skin community, rather than simple bacterial overgrowth.[13][14] That reframing is decisive: if the problem is imbalance, then indiscriminate killing is the wrong tool, and rebalancing is the goal.

Biofilm is the persistence engine. C. acnes readily forms biofilms in the pilosebaceous follicle, and biofilm is strongly implicated in acne persistence, inflammation and treatment failure.[15] In facial biopsies, C. acnes was found as large macrocolonies/biofilms in 37% of acne samples versus only 13% of controls (odds ratio 3.85).[16] Biofilm-embedded cells are markedly more tolerant to antibiotics, and specific virulent phylotypes combine efficient biofilm formation with increased antibiotic tolerance and inflammation.[15][17] Break the biofilm and you undercut both the persistence and the tolerance.

Quorum sensing is the trigger. C. acnes behaves like a well-mannered commensal at controlled densities and turns pro-inflammatory as its population and signalling rise, a quorum-driven switch from “safe” to “danger.”[18] Quenching that signal targets the trigger, not just the symptom.

Proof of concept already exists. Natural actives are being shown, in vitro, to hit exactly these targets, inhibiting C. acnes biofilm and quorum signalling (including AI-2), reducing inflammatory mediators, and in several cases doing so without directly killing the bacteria, i.e. without collateral damage to the microbiome.[19][20][21] The mechanism is real and formulatable; what brands need is a way to measure it in their own products.

(See our Acne-Targeting page.)

The KIND TO BIOME Quorum Quenching Assay

Measure the mechanism. Substantiate the claim.

We developed the Quorum Quenching Assay to evaluate formulations and individual ingredients for their ability to disrupt C. acnes quorum sensing and biofilm formation, the molecular events that turn a skin commensal into a driver of acne.[15][16][18]

Instead of a blunt “does it kill bacteria” readout, the assay characterises what actually matters for microbiome-friendly acne care: whether your product interrupts the signalling and biofilm behaviours that underlie virulence, ideally while leaving the commensal community intact.[6][11] The result is mechanistic evidence you can stand behind, the “adequate and verifiable evidence” that EU cosmetic-claims rules require.[22]

What you get

  • 1A quantitative measure of your formulation's effect on C. acnes biofilm formation.
  • 2An assessment framed around quorum quenching / anti-virulence rather than crude antimicrobial killing.
  • 3Data structured for claim substantiation and R&D decision-making.
Duotone microbiome micrograph illustrating bacterial signalling
Photo slot — duotone SEM microbiome imagery

Claims

What quorum-quenching evidence lets you say — a discussion

An assay doesn't hand you claims; it hands you evidence, and with a mechanism this specific, how you frame the evidence matters as much as the result. Below is where the most defensible language tends to sit, and where the lines are.

Two ground rules

  • Match the data to your product. Every cosmetic claim must be truthful, honest, fair and backed by adequate, verifiable evidence — on your formulation, not just the mechanism in the literature.[22][23]
  • Acne is a disease. “Treats”, “cures” or “gets rid of” acne can reclassify a product as a medicine. Stay on mechanism, the microbiome, and the appearance of blemish-prone skin.[23]

Where quorum-quenching data is strongest — mechanism & ingredient claims

This is territory a “kill everything” antimicrobial can't credibly occupy. When the assay shows your formulation disrupts C. acnes signalling and biofilm, it becomes reasonable to discuss:

  • “Formulated with quorum-quenching technology” / “quorum-sensing–targeting actives” — low-risk, provided the effect is real on your product and the active is deliberately present.[4][15][22]
  • “Helps disrupt the biofilm behaviour of acne-associated bacteria” — keep it on behaviour, not on treating a condition.[15][16]
  • “Targets the communication behind blemish-prone skin, not just the surface” — “blemish-prone” stays cosmetic; “acne-causing” may read as a disease claim in some markets.[4][18]
Macro photograph of human skin
Photo slot — neutral skin macro band

FAQ

Is quorum quenching antibacterial?

Not in the traditional sense. Antibacterials kill or stop bacteria from growing; quorum quenching disrupts how bacteria communicate and coordinate, so it can switch off virulent behaviours like biofilm formation without needing to kill the cell.[4][6] That's why it's described as an anti-virulence strategy.[8][9]

Why is that better than just killing C. acnes?

C. acnes is a normal, largely beneficial resident of healthy skin — acne is linked to an imbalance between strains and a disturbed microbiome, not simply to too much C. acnes.[12][13][14] Killing it indiscriminately can disturb the ecosystem you want to protect and adds selective pressure that favours resistance.[6][8] Quenching the signal targets the harmful behaviour while aiming to leave the community intact.[6][11]

Is there real evidence this works?

Yes. Quorum sensing and quorum quenching are extensively characterised in the microbiology literature [1][2][4]; C. acnes biofilm is significantly more prevalent in acne skin than in controls [16]; the skin's own commensals use quorum quenching to protect the barrier [11]; and multiple natural actives have been shown in vitro to inhibit C. acnes biofilm and signalling.[19][20][21] Our assay lets you generate this evidence for your formulation.

What can I actually claim on-pack?

See the “Claims you can enable” section above. In short: you can make mechanism, biofilm, balance and appearance claims backed by data, but you must avoid disease-treatment language (“treats/cures acne”), which can reclassify your product as a medicine under EU law.[22][23]

Does the assay work on finished formulations or just single ingredients?

Both — we evaluate formulations and individual ingredients for their effect on C. acnes biofilm formation.

References

  1. 1.Miller MB, Bassler BL. Quorum sensing in bacteria. Annu Rev Microbiol. 2001;55:165–199. doi:10.1146/annurev.micro.55.1.165 (PMID: 11544353).
  2. 2.Papenfort K, Bassler BL. Quorum sensing signal-response systems in Gram-negative bacteria. Nat Rev Microbiol. 2016;14(9):576–588. doi:10.1038/nrmicro.2016.89 (PMID: 27510864).
  3. 3.Mukherjee S, Bassler BL. Bacterial quorum sensing in complex and dynamically changing environments. Nat Rev Microbiol. 2019;17(6):371–382. doi:10.1038/s41579-019-0186-5 (PMID: 30944413).
  4. 4.Grandclément C, Tannières M, Moréra S, Dessaux Y, Faure D. Quorum quenching: role in nature and applied developments. FEMS Microbiol Rev. 2016;40(1):86–116. doi:10.1093/femsre/fuv038 (PMID: 26432822).
  5. 5.Fetzner S. Quorum quenching enzymes. J Biotechnol. 2015;201:2–14. doi:10.1016/j.jbiotec.2014.09.001 (PMID: 25220028).
  6. 6.Chen F, Gao Y, Chen X, Yu Z, Li X. Quorum quenching enzymes and their application in degrading signal molecules to block quorum sensing-dependent infection. Int J Mol Sci. 2013;14(9):17477–17500. doi:10.3390/ijms140917477 (PMID: 24065091).
  7. 7.Welsh MA, Blackwell HE. Chemical probes of quorum sensing: from compound development to biological discovery. FEMS Microbiol Rev. 2016;40(5):774–794. doi:10.1093/femsre/fuw009 (PMID: 27268906).
  8. 8.Rutherford ST, Bassler BL. Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb Perspect Med. 2012;2(11):a012427. doi:10.1101/cshperspect.a012427 (PMID: 23125205).
  9. 9.Fleitas Martínez O, Cardoso MH, Ribeiro SM, Franco OL. Recent advances in anti-virulence therapeutic strategies. Front Cell Infect Microbiol. 2019;9:74. doi:10.3389/fcimb.2019.00074 (PMID: 31001485).
  10. 10.Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018;16(3):143–155. doi:10.1038/nrmicro.2017.157 (PMID: 29332945).
  11. 11.Williams MR, Costa SK, Zaramela LS, et al. Quorum sensing between bacterial species on the skin protects against epidermal injury in atopic dermatitis. Sci Transl Med. 2019;11(490):eaat8329. doi:10.1126/scitranslmed.aat8329 (PMID: 31043573).
  12. 12.Fitz-Gibbon S, Tomida S, Chiu BH, et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol. 2013;133(9):2152–2160. doi:10.1038/jid.2013.21 (PMID: 23337890).
  13. 13.Dréno B, Dagnelie MA, Khammari A, Corvec S. The skin microbiome: a new actor in inflammatory acne. Am J Clin Dermatol. 2020;21(Suppl 1):18–24. doi:10.1007/s40257-020-00531-1 (PMID: 32910436).
  14. 14.Brüggemann H, Salar-Vidal L, Gollnick HPM, Lood R. A Janus-faced bacterium: host-beneficial and -detrimental roles of Cutibacterium acnes. Front Microbiol. 2021;12:673845. doi:10.3389/fmicb.2021.673845 (PMID: 34135880).
  15. 15.Coenye T, Spittaels KJ, Achermann Y. The role of biofilm formation in the pathogenesis and antimicrobial susceptibility of Cutibacterium acnes. Biofilm. 2021;4:100063. doi:10.1016/j.bioflm.2021.100063 (PMID: 34950868).
  16. 16.Jahns AC, Lundskog B, Ganceviciene R, et al. An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case–control study. Br J Dermatol. 2012;167(1):50–58. doi:10.1111/j.1365-2133.2012.10897.x (PMID: 22356121).
  17. 17.Cavallo I, Sivori F, Truglio M, et al. Skin dysbiosis and Cutibacterium acnes biofilm in inflammatory acne lesions of adolescents. Sci Rep. 2022;12(1):21104. doi:10.1038/s41598-022-25436-3 (PMID: 36473894).
  18. 18.Lwin SM, Kimber I, McFadden JP. Acne, quorum sensing and danger. Clin Exp Dermatol. 2014;39(2):162–167. doi:10.1111/ced.12252 (PMID: 24524558).
  19. 19.Cañellas-Santos M, Rosell-Vives E, Montell L, et al. Anti-inflammatory and anti-quorum sensing effect of Camellia sinensis callus lysate for treatment of acne. Curr Issues Mol Biol. 2023;45(5):3997–4016. doi:10.3390/cimb45050255 (PMID: 37232724).
  20. 20.Kim YG, Lee JH, Kim SH, et al. Inhibition of biofilm formation in Cutibacterium acnes, Staphylococcus aureus, and Candida albicans by the phytopigment shikonin. Int J Mol Sci. 2024;25(4):2426. doi:10.3390/ijms25042426 (PMID: 38397101).
  21. 21.Kupke IA, Spittaels KJ, Coenye T, Lall N. Anti-quorum-sensing activity of Plectranthus species in multispecies Cutibacterium acnes–Staphylococcus epidermidis systems. Phytomedicine. 2024. doi:10.1016/j.phymed.2024.158260 (PMID: 42119451).
  22. 22.Commission Regulation (EU) No 655/2013 laying down common criteria for the justification of claims used in relation to cosmetic products. Official Journal of the European Union, 2013. (Requires claims to be legally compliant, truthful, evidentially supported by “adequate and verifiable evidence,” honest, fair, and to allow informed decision-making.)
  23. 23.Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products. Official Journal of the European Union, 2009. (Defines cosmetic products and the framework distinguishing them from medicinal products.)